OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formation of subsidiary OS Drug Conjugates (OSDC) ...

Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K. Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K. Warwick Medical School ...

Rubidium could be the next key player in oxide-ion conductors. Researchers at the Institute of Science Tokyo have discovered ...

School of Civil and Environmental Engineering, The University of New South Wales, Sydney, New South Wales 2052, Australia School of Environmental Science and Engineering, Guangdong Provincial Key ...

Triple click chemistry has revolutionized chemical synthesis with its simplicity and efficiency, allowing for the quick and selective assembly of complex molecules. Now, in a recent study, researchers ...

Japanese researchers from the Institute of Science Tokyo (Science Tokyo) have developed a new material that could ...

Although these "trivalent" platforms enable the efficient synthesis of complex compounds, the selective formation of ...

Although these "trivalent" platforms enable the efficient synthesis of complex compounds, the selective formation of ...

Rubidium could be the next key player in oxide-ion conductors. Researchers at Institute of Science Tokyo have discovered a ...